The Drosophila mushroom bodies, centers of olfactory learning and memory in the fly 'forebrain', develop from a set of neural stem cells (neuroblasts) that generate a large number of Kenyon cells (KCs) during sustained cell divisions from embryonic to late pupal stage. We show that retinal homeobox (rx), encoding for an evolutionarily conserved transcription factor, is required for proper development of the mushroom bodies. Throughout development rx is expressed in mushroom body neuroblasts (MBNBs), their ganglion mother cells (MB-GMCs) and young KCs. In the absence of rx function, MBNBs form correctly but exhibit a reduction in cell size and mitotic activity, whereas overexpression of rx increases growth of MBNBs. These data suggest that Rx is involved in the control of MBNB growth and proliferation. Rx also promotes cell cycling of MB-GMCs. Moreover, we show that Rx is important for the survival of MBNBs and Kenyon cells which undergo premature cell death in the absence of rx function. Simultaneous blocking of cell death restores the normal set of MBNBs and part of the KCs, demonstrating that both, impaired proliferation and premature cell death (of MBNBs and KCs) account for the observed defects in mushroom body development. We then show that Rx controls proliferation within the MBNB clones independently of Tailless (Tll) and Prospero (Pros), and does not regulate the expression of other key regulators of MB development, Eyeless (Ey) and Dachshund (Dac). Our data support that the role of Rx in forebrain development is conserved between vertebrates and fly.
Introduction
In Drosophila, the brain develops from a bilaterally symmetrical array of about 100 neural stem cells (Younossi-Hartenstein et al., 1996; Urbach et al., 2003) , called neuroblasts (NBs) , that proliferate in a temporally and spatially regulated manner to produce the enormous number and diversity of neural cells. During early embryonic development NBs delaminate from the neuroectoderm and shortly thereafter start to undergo repeated asymmetric cell divisions to produce ganglion mother cells (GMCs) that each divide once to generate two differentiated cells (reviewed in Urbach and Technau, 2004) . After a period of mitotic dormancy, embryonic brain NBs become reactivated in the larva to generate most of the adult CNS (Ito and Hotta, 1992; Pereanu and Hartenstein, 2006) . Changes in the nutritional status upon food intake during larval stages activate the insulin and target of rapamycin pathways in dormant NBs to induce growth and the re-entry into cell cycle (Chell and Brand, 2010; Sousa-Nunes et al., 2011) . Brain NBs proliferate until third instar or pupal stage, depending on the NB-lineage, and terminate proliferation by final differentiation or apoptosis (Ito and Hotta, 1992; Bello et al., 2003; Maurange et al., 2008; Siegrist et al., 2010) . The adult brain consists of about 100 NB-lineages per hemisphere (Pereanu and Hartenstein, 2006; Ito et al., 2013; Yu et al., 2013) , suggesting that almost all embryonic brain NBs become reactivated postembryonically.
Four NBs per brain hemisphere (called MBNBs) generate the large number of intrinsic neurons of the adult mushroom bodies (MBs) (Ito and Hotta, 1992; Prokop and Technau, 1994; , called Kenyon cells (KCs) . The MBs are a pair of prominent central brain structures in the fly 'forebrain' (i.e. the protocerebrum; Urbach, 2007) playing an essential role in olfactory learning and memory (Heisenberg, 2003; Davis, 2011) . The MBNBs behave differently from other NBs as they divide continuously from the embryonic to the late pupal stage (Truman and Bate, 1988; Ito and Hotta, 1992; Prokop and Technau, 1994; Stocker et al., 1995) . During the postembryonic period each MBNB sequentially generates three types of KCs (γ-neurons, α′/ β′-neurons, α/β-neurons) which extend dendrites into the calyx and axons through a massive tract, called the peduncle, into the five distinct lobes (the vertical α-, α′-lobes, and the medial β-, β′-, γ-lobe) of the adult MB (Ito et al., 1997; Armstrong et al., 1998; Crittenden et al., 1998; Noveen et al., 2000; Kurusu et al., 2002; Strausfeld et al., 2003; Tanaka et al., 2008) . The organisation of the larval MB is simpler than the adult MB, as the lobe system consists of only one medial and one vertical lobe, both innervated by γ-neurons (Figs. 1D; 2B) (Kurusu et al., 2002; Noveen et al., 2000; Tettamanti et al., 1997) .
The mechanisms controlling the unique developmental characteristics of the MBNBs are largely unknown. Molecular and genetic studies have shown that the transcription factors Eyeless (Ey), Dachshund (Dac), and Tailless (Tll) are key regulators of MB development (Kurusu et al., 2000; Martini et al., 2000; Noveen et al., 2000; Callaerts et al., 2001; Kurusu et al., 2009) . Whereas Ey and Dac are essentially involved in KC differentiation (Kurusu et al., 2000; Martini et al., 2000; Noveen et al., 2000; Callaerts et al., 2001) , Tll has been shown to be required for efficient proliferation and maintenance of MB progenitors (Kurusu et al., 2009 ). We previously found that retinal homeobox (rx) is expressed in the embryonic primordia of the MBs (Kunz et al., 2012) . The rx gene, evolutionary well conserved from fly to human, encodes for a transcription factor containing a paired-like homeodomain (Mathers et al., 1997; Eggert et al., 1998; Ohuchi et al., 1999; Walldorf et al., 2000; Bailey et al., 2004; D'Aniello et al., 2011; reviewed in Muranishi et al., 2012) . Here we show that Rx is expressed in MBNBs, their GMCs (MB-GMCs) and young KCs throughout development, and is required for proper development of the MBs. In loss-and gain-offunction experiments we demonstrate that Rx positively regulates cell size and mitotic activity of MBNBs, and also promotes the mitotic activity of MB-GMCs. We find that rx-mutant MBNBs and KCs undergo premature cell death. As the wild-typic set of MBNBs and a proportion of KCs is restored upon blocking cell death in the absence of rx function, this demonstrates that premature cell death of MBNBs and KCs, together with the reduced proliferation within MBNB clones account for the observed defects in MB development. We show that Rx acts in parallel to Tll to control proliferation within the MBNB clones. Rx also acts independently of Prospero (Pros), which we find to be needed in MB-GMCs for repression of NB-specific genes and activation of terminal differentiation genes, as in GMCs of other NB-lineages (Vaessin et al., 1991; Li and Vaessin, 2000; Choksi et al., 2006) . We finally show that Rx does not insc N GFP labels the proximal part of a NB lineage (including MBNB, GMCs and young KCs) at larval and pupal stages, and only a remaining set of young KCs at the adult stage (as indicated). Dpn is a marker for NBs, and Elav a marker for postmitotic neurons. Accordingly, white stippled lines encircle Rx/Dpn-positive MBNB (marked with asterisk) and Rx-positive/Elav-negative GMCs, yellow stippled line enclose Elav/ Rx-coexpressing KCs. (C) Brain at embryonic stage 17. Asterisks mark Rx/Dpn-positive MBNBs, white arrows mark other Rx/Dpn-positive NBs. In the embryic CNS, Neurotactin (Nrt) is expressed in the membrane of all cells of the brain. (D) MB in first larval instar (24 h ALH); left hemisphere from a dorsal view. Arrows indicate three of four Rx-positive MB cell clusters (white arrows) within the cortex of an ey N GFP-labeled MB; ey N GFP is expressed in larval KCs. Ca, Calyx; Cx, Cortex; P, peduncle; mL, medial lobe; vL, vertical lobe. (E) Stippled line encircles the MB cortex including the four Rx/Dpn-positive MBNBs (asterisks). (F 1-4 ) Left hemisphere of a late larval brain (L3) from a posterior (p) view. (F 1 ) Schematic overview of groups of brain NB-lineages in vicinity to the MB cortex, according to Pereanu and Hartenstein (2006) . Ol, optic lobe; a, anterior; d, dorsal; v, ventral . Stippled lines in white encircle the MB cortex including the MBNBs (asterisks). (F 2-4 ) nab N GFP is expressed in all brain NBs and most part of their respective lineages. In contrast to the embryo, in larval NB-lineages Neurotactin (Nrt) is expressed in only a cell subset and the corresponding axonal tract. The NB position within the cell cortex and the projection of the axonal tracts into a distinct brain compartment is specific for each NB lineage (Pereanu and Hartenstein, 2006) . Shown are three different sections of the same brain hemisphere. (F 2 ) Composite confocal image disclosing the arrangement of posterior NBs in the outer brain cortex. (F 3, 4 ) Single focal plane at the level of the MB cortex (F 3 ), and calyx (F 4 ). Stippled lines in green encircle part of the DPM-and CMv-lineages (F 2 ), from which a large population of Rx-positive neurons develop (encircled in F 3, 4 ). White arrows in F 2, 4 indicate six other Rx-positive NBs. MBNB clones are identified by their axonal insertion sites into the MB calyx (as indicated by green arrows in F 4 ). Stippled lines in blue indicate midline. Scale bars in B, C, D, E, F 2 : 10 μm. regulate the expression of ey and dac. The requirements of Rx in MB development support that Rx function in forebrain development is conserved between vertebrates and fly.
Results

rx is expressed in MBNBs and their lineages from embryonic to pupal stage
In costainings against Rx and the NB-specific marker Deadpan (Dpn), during embryogenesis we detected Rx protein in 8-10 NBs (per hemisphere) and many other cells of the brain (Fig.1 C) . From embryonic stage 13 onwards, Rx was expressed in all four MBNBs (per hemisphere; see also Kunz et al., 2012) , their GMCs (MB-GMCs) and a subset of newly born KCs (Fig. 1B-F) . This cellular profile of Rx expression was maintained in the MBs until the late pupal stage, indicating that Rx is expressed in MBNBs and GMCs throughout their lifespan (Fig. 1B-F) .
In the larval brain, each NBs occupies a characteristic position within the cortex and generates a highly stereotyped lineage of neurons (Pereanu and Hartenstein, 2006) . The neurons of each lineage form a coherent cluster which is visible when driving membrane-bound GFP (mGFP) with the inscutable (insc)-Gal4 (in the following insc N GFP) or nab-Gal4 driver (nab N GFP) (Fig. 1B, F) . Both Gal4-lines drive expression in the NB and most progeny cells (including GMCs and many neurons) (for insc-Gal4 see also Betschinger et al., 2006) . In addition, both Gal4 driver, as well as Neurotactin (expressed in many postembryonic neurons and their axons), visualize the axonal tract of each lineage which innervates a specific compartment of the brain (Pereanu and Hartenstein, 2006) (Fig. 1F) . Similar to the embryo, about 10 Dpn/Rxpositive NBs per hemisphere were found in the third instar larva (L3). Besides the four MBNBs, we propose that according to the atlas of larval brain NB lineages of Pereanu and Hartenstein (2006) , two Rx/Dpn-positive NBs belong to the DPL (DPLc)-lineages, and the remaining four Rx/ Dpn-positive NBs, most likely, to the CP/CMv-lineages (Fig. 1F 1-3 ). These 10 brain NBs represent all type I NBs, which typically bud off GMCs. Rx was also detected in other brain NB-lineages among which are dorso-medial DPM-lineages, which belong to the type II NB-lineages that contribute to the central complex (also called DM-lineages; Bello et al., 2008; Boone and Doe, 2008; Izergina et al., 2009; Pereanu et al., 2010; Yang et al., 2013) (Fig. 1F 1 ) . Type II NBs, in contrast to type I NBs, generate transit amplifying intermediate progenitors which themselves undergo several asymmetric divisions to produce GMCs (Bello et al., 2008; Boone and Doe, 2008; Bowman et al., 2008; reviewed in Reichert, 2011; Homem and Knoblich, 2012) . In the DPM-lineages, opposite to the MBNB-lineages, Rx is usually restricted to more distally located cells which express Embryonic lethal abnormal vision (Elav) (data not shown), a marker specific for differentiated neurons (Robinow and White, 1988; Lisbin et al., 2001) ; in these lineages, Rx is neither detected in the NB, nor in transient amplifying precursor cells or GMCs (Fig. 1F 2 ,  F 3 ). Accordingly, Rx seems to be expressed in fairly complementary cell types in the DPM-lineages and MBNB-lineages. 
Rx does not control formation of embryonic MBNBs
During development of the MBNBs, Rx is already expressed in the embryonic neuroectoderm of the MB primordia (Fig. 1A) Fig. 2A) . A maternal contribution of rx could be excluded since neither rx mRNA (Eggert et al., 1998) nor Rx protein was detectable at early embryonic stages. We conclude that Rx does not regulate the formation of MBNBs.
Rx promotes proliferation of MBNBs and MB-GMCs
Since Rx is prominently expressed in the developing MBs, we asked whether Rx influences the number of MB cells. Indeed, the number of Ey-positive cells was reduced by about 14% in the late embryonic MB cortex (stage 17) of rx 10155 null mutants, as compared to wild-type ( Fig. 2B ). As we show later (see Section 2.7.), this reduction is not due to a deregulation of Ey expression in the absence of Rx. To assay the function of Rx in postembryonic MB development, we induced rx-mutant MARCM-clones and performed rx-RNAi experiments, using two different UAS-rx-RNAi-lines (UAS-rx44716-RNAi, UAS-rx106185-RNAi) and the insc-Gal4 driver line. Both UAS-rx-RNAi lines recapitulated the phenotype observed in rx-mutant MARCM clones, indicating that the RNAi phenotype is specific. Upon insc N rx44716-RNAi, we detected a strong decrease in the number of Ey-positive MB cells (by~35%) at 72 h after puparium formation (APF) (Fig. 2C ). In accordance with these observations, we found a reduction in the cell number of rx
10155
-mutant MARCM-induced MBNBclones in L3 at 96 h after larval hatching (ALH) (182.06 ± 8.65 cells, n = 47), as compared to wild-type (217.60 ± 2.93 cells, n = 45) ( Fig. 2D-I′) ; in one case a rx 10155 -mutant MBNB-clone consisted of only~25 KCs (Fig. 2G ). The average reduction in cell number was even more pronounced in mutant clones at mid-pupal stages (36-48 h APF) (Fig. 2D, H, I ). This reduction in MB cells could be due to defects in proliferation of MBNBs and MB-GMCs, or apoptosis of MBNBs and/or progeny cells. To see if proliferation is affected we performed EdU-experiments after rxRNAi (insc N rx44716-RNAi). After a 5, 5 h EdU-pulse the number of EdU-labeled daughter cells was reduced in MBs of late L3 brains (insc N rx44716-RNAi: 7.27 ± 0.22, n = 67 clones; wt: 7.94 ± 0.18, n = 99; *p = 0.018) (Fig. 3A, B ). This supports that the mitotic capability of proliferative cell types (MBNB, GMCs) is reduced in the MB. Therefore, we next assayed the mitotic activity of MBNBs in stainings against the mitotic marker Phospho-histone 3 (PH3). The mitotic index of MBNBs was markedly decreased in rx 10155 -mutant late embryos (bỹ 27%), and upon rx-RNAi (insc N rx44716-RNAi) at L3 (by~15%); also the frequency of mitotic MBNBs in rx 10155 -mutant MARCM clones at L3 was strongly reduced (Fig. 2J ).
Next we assayed the number and mitotic activity of MB-GMCs in the absence of rx. In MARCM-labeled MBNB-clones, membrane-bound GFP is expressed in all cells, similar to insc-Gal4 driven GFP (but which is not expressed in distal KCs). In combination with a staining against the neuronal marker Elav, MB-GMCs (GFP-positive/Elav-negative) could be distinguished from young KCs (GFP-positive/Elav-positive) in MARCMand insc N GFP-labeled clones. We found that, in accordance with the reduced mitotic activity of MBNBs, the number of MB-GMCs was diminished: by~16% upon insc N rx44716-RNAi at L3, and by~22% in midpupal rx 10155 -mutant MARCM clones (both ***p b 0.001) (Fig. 3C, D) .
Additionally, the mitotic index of MB-GMCs was reduced nearby half (~44%) upon insc N rx44716-RNAi, as compared to wild-type (Fig. 3E, F) . Altogether, our data indicate that Rx is essential for normal proliferation levels throughout MBNB lifespan, and in addition promotes proliferation of MB-GMCs. Notably, in the absence of Rx the mitotic activity of MBNBs seemed to be reduced to a stronger extent than the final number of MB-GMCs. As also the mitotic activity of rx-mutant MB-GMCs was diminished, we assume that MB-GMCs undergo a prolonged cell cycle, or may arrest.
Rx promotes cell growth of MBNBs and other brain NBs
Proliferation of NBs is closely correlated with cell size (Maurange et al., 2008; Chell and Brand, 2010; Melzer et al., 2013) . To investigate whether the reduced mitotic activity of rx-mutant MBNBs goes along with a reduction in cell size, we measured the diameter of the four individually identifiable MBNBs. At embryonic stage 17, the cell size of all four MBNBs (per side) was reduced; further, this reduction appeared in a MBNB-specific manner: while MBNBa showed the strongest decrease in cell diameter (on average~1.55 μm), MBNBc was affected least (on average~0.48 μm) (Fig. 4A, B) . Interestingly, these MBNB-specific differences resemble the endogenous rx expression, as MBNBa expresses rx from its time point of formation (stage 9), and MBNBc significantly later (not before stage 13; Kunz et al., 2012) . We then measured the cell size of postembryonic MBNBs in rx 10155 -mutant MARCM clones. Their diameter was reduced at late larval (by~11.6% at 96 h ALH) and mid-pupal (~11.1% at 36-48 h APF) stage, as compared to control MBNBs in wild-type clones (96 h ALH: 11.93 ± 0.11 μm, n = 55; 36-48 h APF: 11.89 ± 0.14 μm, n = 36). rx-knockdown experiments (insc N rx44716-RNAi) resulted in a similar reduction of the larval MBNB cell diameter (~13.1% at 96 h ALH) ( Fig. 4C-E) . Among the population of late larval rx-RNAi MBNBs we recognized some with a diameter between 8 and 10 μm, thus, smaller or commensurate to embryonic MBNBs (Fig. 4D) , suggesting that those MBNBs do not grow at all during larval development.
To attribute the observed defects in MBNB size and proliferation specifically to Rx function, we performed rx-overexpression experiments. Using insc-Gal4, or elav-Gal4 which also drives expression in larval brain NBs (Pereanu and Hartenstein, 2006) , at L3 we observed an increase in MBNB cell diameter on average of 0.74 μm (in insc N rx) and 1, 1 μm (in elav N rx), corresponding to an average overgrowth of 6.3% and 9.4%, respectively, as compared to wild-type MBNBs (Fig. 4C-E) .
In order to see if Rx is competent to enhance cell growth also of other brain NBs that do not endogenously express rx, we assayed NBs belonging to BLD (basolateral dorsal)-and BLP (basolateral posterior)-lineages (according to Pereanu and Hartenstein, 2006) (Fig. 4K 3 ) . Upon rx-overexpression (insc N rx) the cell diameter of these NBs was significantly increased by~11.1% at 96 h ALH, now corresponding with the average cell diameter of wild-typic MBNBs (Fig. 4G , H, K 1 , K 2 ); in some cases, we observed strongly over-sized brain NBs with a diameter of up to 15 μm (Fig. 4G) . Additionally, the cell diameter of the corresponding GMCs was slightly increased (Fig. 4J) . These data show that Rx is sufficient to enhance cell growth in MBNBs and other brain NBs.
To test whether the Rx-induced increase in cell size is correlated with mitotic activity we counted the mitotic index of larval MBNBs and BLD-/BLP-NBs (see Fig. 4K 3 ). Upon insc N rx 33.7% (n = 95) and upon elav N rx 33.6% (n = 125) of larval brain MBNBs (96 h ALH) were mitotic, thus only slightly more than of control MBNBs (32.6%, n = 132) (Fig. 4I) . Similarly, the mitotic activity of NBs in the BLD-/ BLP-region was only moderately enhanced after ectopic expression of rx (elav N rx: 39.26% of NBs, n = 72), as compared to control NBs (37.62% of NBs, n = 65) (Fig. 4I) .
Together, these data demonstrate that Rx controls cell growth of embryonic and postembryonic MBNBs and is sufficient to induce cell growth also in other brain NBs. Loss of Rx function leads to a reduction of MBNB cell size and a decrease in their mitotic activity. Oppositely, rxoverexpression results in increased cell size of MBNBs and other brain NBs, which is correlated with a slight gain in their mitotic activity.
We further noticed that the cell diameter of larval MB-GMCs was slightly increased upon rx-overexpression (insc N rx) and reduced after insc N rx44716-RNAi at 96 h ALH (Fig. 4F) . We suppose that the decrease in cell size also impinges on the mitotic activity of MB-GMCs, which, as shown above (see Section 2.3.), is reduced after rx-RNAi. As the relative change in cell size of MB-GMCs correlates with MBNBs upon rx-RNAi (decrease by 13-14% of cell diameter) or rx-overexpression (increase by 4-6% of cell diameter), we assume that the changes in MB-GMC size is indirectly due to alteration in size of the parental MBNB.
Rx is critical for the survival of MBNBs and KCs
MBNBs persist normally until the late pupal stage (96 h APF) (Siegrist et al., 2010; own observations) . We observed that MBNBs were occasionally missing in rx-mutant MARCM-labeled MBNB-clones at late larval (96 h ALH) or midpupal stages (36-48 h APF) (n = 4; Fig. 2G, I ), but were never detected at 72 h APF (n = 84). Similarly, upon rx-RNAi (insc N rx44716-RNAi) MBNBs were rarely missing in late larval/midpupal stages (n = 3), whereas only 1-3 MBNBs were found in~50% of hemispheres at 72 h APF (n = 19 MBs) (Fig. 5A 2 , B) , opposite to control MBs (insc-Gal4) with consistently four MBNBs (Fig. 5A 1 , B) . These data suggest that rx-deficient MBNBs undergo premature cells death. To investigate to which extent rx-deficient MBNBs can be restored by blocking cell death, we misexpressed the cell death blocker p35, an inhibitor of active caspases (Hay et al., 1995) , in rxRNAi background (insc N rx44716-RNAi + p35). Notably, the wild-type number of four MBNBs was restored in 96% of hemispheres in 72 h old pupa (n = 28 MBs) (Fig. 5A 3 , B) .
We further observed that the total cell number in MARCM-induced mid-pupal rx-mutant MBNB-clones was considerable smaller than in late larval rx-mutant MBNB-clones ( Fig. 2D-I ; as described in Section 2.3.). Since MBNB-clones normally continuously grow (Fig. 2D ) until 85-90 h APF, when MBNBs terminate division (Ito and Hotta, 1992) , this progressive decrease in rx-mutant clone size during larval and pupal development cannot be explained by defects in proliferation alone, but most likely by cell death of daughter cells of the MBNBs. To see if upon blocking cell death in rx-knockout condition (insc N rx44716-RNAi + p35) also the number of MBNB daughter cells is restored, we counted the number of Ey-positive MB cells. Whereas control MBs contained 944.17 ± 10.15 Ey-positive cells (n = 6 MBs) at 72 h APF, after rx-RNAi the number of Ey-positive MB cells was reduced by~35% (insc N rx44716-RNAi: 614.20 ± 22.12, n = 5 MBs) (Fig. 5A 2 , C) . This reduction of MB cells was significantly smaller (bỹ 22%) upon simultaneous targeted expression of p35 (insc N rx44716-RNAi + p35: 736.01 ± 31.73, n = 5 MBs; **p = 0.006) (Fig. 5A 3 , C) . The number of Ey-positive KCs cells in wild-type MBs (at 72 h APF) is lower than expected (for KC number see Technau and Heisenberg, 1982; Aso et al., 2009 ), but Ey may not be detectably expressed in all KCs throughout development. C 3 ) , in insc N GFP-labeled MBNB clones in wild-type (C 5 ), upon rx loss-of-function (C 2 , C 4 , C 6 ) and after rx-overexpression (C 7 , C 8 ), at indicated stages. White stippled outlines indicate MBNBs. Cell membrane of MBNBs is marked by insc N GFP (C 1-7 ), and by Phalloidin-staining in (C 8 ). Scale bar: 10 μm. (D) Distribution of MBNB cell sizes in wild-type (inscGal4), rx loss-of-function (insc N rx44716-RNAi) and rx gain-of-function (insc N rx, elav N rx) at 96 h ALH, and in wild-type at embryonic stage 17, according to the color code. The average cell diameter of MBNBs (see also E) is reduced upon insc N rx44716-RNAi (n = 82, blue area indicates proportion of exceptionally small MBNBs) and increased upon insc N rx (n = 165) or elav N rx (n = 155, green area indicates proportion of exceptionally large MBNBs), as compared to insc-Gal4 (n = 176). Note that the distribution of MBNB cells sizes upon insc N rx44716-RNAi at 96 h ALH is similar to that in wild-type embryos at stage 17. (E) Quantification of the average MBNB cell diameter in rx loss-of-function at 96 h ALH (inscGal4 (control): 11.84 ± 0.08 μm, n = 176; insc N rx44716-RNAi: 10.29 ± 0.90 μm, n = 82; **p = 0.009; ***p b 0.001 and MARCM wt: 11.93 ± 0.11 μm, n = 55; MARCM rx: 10.54 ± 0.10 μm, n = 69; ***p b 0.001), and at 36-48 h APF (MARCM wt: 11.89 ± 0.14 μm, n = 36; MARCM rx: 10.59 ± 0.10 μm; n = 44; ***p b 0.001), and after rx-overexpression at 96 h ALH (insc N rx: 12.58 ± 0.10 μm, n = 165; elav N rx: 12.95 ± 0.1 μm, n = 155; ***p b 0.001). n.s., not significant. (F) The cell diameter of MB-GMCs is significantly reduced upon rxRNAi (insc-Gal4: 4.72 ± 0.05 μm, n = 140; insc N rx44716-RNAi: 4.07 ± 0.05 μm, n = 82; ***p b 0.001) and increased upon rx-overexpression (insc N rx: 4.88 ± 0.05 μm, n = 52, *p = 0.031) at 96 h ALH. Scored were only those three to five Elav-negative MB-GMCs lying closest to the parental MBNB. (G) Distribution of the cell diameters of NBs in BLD-and BLP-lineages (see J 1-3 ) in insc-Gal4 (control) and after rx-overexpression (insc N rx) at 96 h ALH. After insc N rx the average cell diameter of those NBs is increased. Some enlarged NBs are outside of the wild-type range (area right-hand to the stippled line). (H) Quantification of the average cell diameter of BLD-/BLP-NBs at 96 h ALH in insc-Gal4 (control: NB inscGal4: 10.65 ± 0.10 μm, n = 125) and after rx-overexpression (NB insc N rx: 11.93 ± 0.09 μm, n = 124, ***p b 0.001), as compared to MBNBs (MBNB insc-Gal4: 11.84 ± 0.08 μm, n = 176). Assayed were about 8-10 BLD-/BLP-NBs per hemisphere. Note that the average cell diameter does not differ between rx-overexpressing BLD-/BLP-NBs and wild-type MBNBs Interestingly, the number of MB-GMCs was not increased after simultaneous misexpression of p35 (insc N rx44716-RNAi: 4.80 ± 0.21, n = 23 MBNB-clones; insc N rx44716-RNAi + p35: 5.12 ± 0.26, n = 22 MBNB-clones; p = 0.289), suggesting that MB-GMCs do not undergo cell death in the absence of Rx function. Thus, blocking cell death in Rx absence restored the normal set of MBNBs and a substantial fraction (~13%) of KCs. However, the larger proportion of KCs (~22%) could not be restored, which suggests that proliferation defects within the MBNB-lineages account for their absence.
Since rx is persistently expressed in MBNBs throughout lifespan, we wondered if via targeted expression of rx with worniu-Gal4 or insc-Gal4, both driving expression in MBNBs until late pupal stage, the durability of MBNBs can be prolonged. As under these conditions, the longevity of MBNBs was unaltered (data not shown), this indicates that Rx alone is not sufficient to expand the survival of MBNBs.
Rx controls proliferation in MBNB-lineages independent of Tll and Pros
Next, we investigated if Tll, required for efficient proliferation and prolonged maintenance of MB progenitors (Kurusu et al. 2009 ), interacts with Rx. tll expression is found in most protocerebral brain NBs by embryonic stage 11 (Urbach and Technau 2003) , but becomes confined to MBNBs and MB-GMCs until stage 17 (Kurusu et al. 2009 ) (including also few young KCs; Melzer et al., 2013) , in which tll expression stays until late pupal stage; accordingly, the expression profiles of tll and rx closely correspond (Fig. 6A, C) . To see if Rx regulates tll expression, we assayed the number of Tll-positive cells in MARCM-induced rx-mutant MBNB-clones at late L3; this number was reduced by 23% (n = 18 clones) (Fig. 6A, B) . However, as shown above (Section 2.3.), the number of MB-GMCs was reduced (by 19%) in rx-mutant clones (Fig. 3D) , and the mitotic activity of remaining MB-GMCs diminished (by 44%) (Fig. 3F) . Therefore, we conclude that the reduction of Tll-positive cells is rather indirectly caused by the proliferation defects within the MBNB-lineages, but not due to Rx regulating tll expression. Consistent with these findings, we observed no alteration in the number of Tll-positive MB cells after rx-overexpression (n = 76 clones) (Fig.  6B ). Next, we tested the number of Rx-positive MB cells after tll-RNAi (insc N tll-RNAi). The number was slightly diminished (Fig. 6C, D) , which is likely due to the fact that the number of MB-GMCs is reduced in tll mutants (Kurusu et al. 2009 ). Taken together, we conclude that Tll and Rx act independently of each other in MB development.
We recognized that Prospero (Pros), a crucial neuronal pro-differentiation factor (Choksi et al. 2006; Li and Vaessin 2000) , is cortically localized in the cell cortex of MBNBs and segregates into the MB-GMC during NB division (Fig. 7A) . Pros is detected in MB-GMCs and maintained at low levels in most, if not all, KCs at L3 (Fig. 7B-C) . Since Pros and Rx are coexpressed in a subfraction of MB cells, we tested if Rx regulates expression of Pros. Upon rx-RNAi (insc N rx106185-RNAi) expression of pros was principally unaltered in MB cells at late L3 (n = 7), except that the number of Pros-positive MB cells was reduced (Fig. 7C) , in compliance with the observed underproliferation phenotype in MBNB-lineages in the absence of Rx, as shown above (Section 2.3.). Pros expression was also unchanged in MB cells after rx-overexpression (n = 9) (Fig.  7D) . Accordingly, Rx seems not to control pros expression in MBNB-lineages. To find out if, conversely, Pros regulates rx expression in MBNBlineages, we tested Rx after pros-RNAi (insc N pros-RNAi). Loss of pros induces an overproliferation phenotype in lineages of other brain NBs, since GMCs derepress NB-specific genes and fail to exit the cell cycle (Bello et al. 2006; Betschinger et al. 2006; Choksi et al. 2006; Lee et al. 2006; Kurusu et al. 2009 ). We observed this phenotype also upon pros-RNAi in larval MBNB-lineages. The MB cortex in these larvae was significantly enlarged at L3, indicating extensive cell divisions (Fig.  7E-I) . A large fraction of the supernumerary, heterogeneous sized, partly NB-like cells expressed the stem cell marker Dpn (Fig. 7G, G′) , and almost all MB cells expressed Tll (Fig. 7E, F, F′) and Rx (both normally detected preferentially in MBNBs and MB-GMCs) (Fig. 7H, I ), followed by a marked loss of KCs expressing neuron-specific Elav (Fig. 7J, K and Dac (data not shown). Since most MB cells express rx upon prosRNAi this could imply that Pros normally suppresses rx in MBNB-lineages. However, this seems unlikely as pros and rx are normally coexpressed in MB-GMCs and young KCs. We therefore assume that upon pros-knockdown rx is indirectly upregulated in MBNB-lineages, as supernumerary cells acquire a MBNB-like fate, which typically express Rx.
Rx controls MB development in parallel with Dac, and does not regulate expression of ey
Finally, we asked if Rx interacts with Ey and Dac, which are key regulators of MB development and KC differentiation (Kurusu et al. 2000; Noveen et al. 2000) . Ey is expressed in KCs of the embryonic and postembryonic MB (Fig. 6E) (Kurusu et al. 2000; Noveen et al. 2000; Callaerts et al. 2001; Adachi et al. 2003; Kunz et al. 2012) . In order to see if Rx regulates the expression of ey, we examined Ey in MARCM-induced rx-mutant MBNB-clones. The number of Ey-positive cells was diminished, which is in compliance with the reduction of the rx-mutant MBNB-clone size (Fig. 6E) . Since all remaining KCs in the reduced MBNB-lineage still expressed Ey (n = 19 clones; Fig. 6E ), this suggests that Rx does not positively regulate ey expression.
Although Dac and Rx are coexpressed in many KCs during embryonic development, we recognized that both factors become complementarily expressed during larval MB development (Fig. 6F) , raising the possibility of repressive interaction. First we tested if Rx regulates dac expression. Normally, Dac expression is excluded from MBNB, MBGMCs and young KCs (together 27.44 ± 0.48 cells/clone at L3) (Fig.  6F ). This number of Dac-negative MB cells was reduced upon rx-RNAi (insc N rx44716-RNAi) (Fig. 6G, H) , which is in correspondence with the observed proliferation defects in rx-knockdown MBNB clones. Further, the number of Dac-negative MB cells was unaltered after rx-overexpression (insc N rx) (Fig. 6H) , indicating that ectopic Rx does not repress dac in more distal clonal cells. Both experiments suggest that Rx does not control dac expression. To test if, oppositely, Dac represses rx expression, we applied dac-RNAi (insc N dac-RNAi) and dac-overexpression (insc N dac). The number of Rx-positive MB cells was unaltered under both experimental conditions (Fig. 6I) , suggesting that Dac does not repress expression of rx.
Discussion
The function of Rx in brain development is largely unknown. In this study we reveal a role of Rx in the development of the MBs. These structures develop from a small and particular set of brain NBs, that behave differently from other NBs as they continuously divide from the embryonic to the late pupal stage (~85-90 h APF; Truman and Bate 1988; Ito and Hotta 1992) . MBNBs represent the largest progenitors in the CNS which, despite permanent division, continuously grow until the late larval stage (Melzer et al., 2013) . Interestingly the time window of rx expression closely correlates with the mitotic period of these MBNBs, suggesting a specific function in the control of MBNB growth and proliferation.
Rx function in growth and proliferation control of MBNBs
We find that Rx is needed to promote normal proliferation levels of MBNBs (and MB-GMCs) throughout lifespan. The molecular mechanism by which Rx controls proliferation is unclear. Although rx and tll exhibit remarkable similarities in the expression profile in MB cells, and both promote proliferation of MBNBs and MB-GMCs (for tll see Kurusu et al. 2009 ), both factors act independently in MBNB lineage development. Indeed, Rx and Tll also show functional differences: Whereas Rx induces growth of MBNBs, this was not observed for Tll (Kurusu et al. 2009 ). Further, Rx prevents premature cell death of MBNBs and KCs, while Tll prevents cell death of MBNB-GMCs, but not of MBNBs, even though Tll is required for their maintenance; finally, unlike ectopic Rx, ectopic Tll evokes the development of supernumerary brain NBs (Kurusu et al. 2009 ).
Dac, another key regulator of KC differentiation is expressed in almost all KCs, complementary to Rx in MBNBs and MB-GMCs. Interestingly, Dac has recently been reported to be an inhibitor of cell proliferation in the eye imaginal disc (Bras-Pareira et al., 2015) . The conspicuous expression pattern of Dac and Rx thus raised the possibility, that repressive interactions between Dac and Rx could impact the proliferation in MBNB-lineages. Our data show that both factors do not control each other's expression. Further, Dac-knockdown or Dacoverexpression seem not to alter the mitotic activity in MBNB-lineages, which is in compliance with the previous finding that the cell number is unchanged in dac-mutant MARCM-clones (Martini et al. 2000) . These results argue against an anti-proliferative function of Dac in MB development. It has been shown that Dac, Tll, and Ey, all key control factors in MB development, act largely independent of each other (Kurusu et al. 2000; Martini et al. 2000; Noveen et al. 2000; Kurusu et al. 2009 ). As we show that Rx does not interact with Dac and Tll, and Rx does not regulate Ey, this suggests that Dac, Tll, and perhaps Ey (as we cannot exclude that Ey controls rx expression), act in parallel with Rx in MB development.
We find that Pros which controls proliferation in NB lineages, is cortically localized in dividing MBNBs. Rx and Pros, coexpressed in MBNBs and GMCs, do not interact. It was shown that pros-mutant brain NBclones undergo extensive cell division to generate undifferentiated tumours (Bello et al. 2006; Betschinger et al. 2006; Choksi et al. 2006; Lee et al. 2006; Doe 2008) , except in MARCM-induced pros-mutant MBNB-clones (Kurusu et al. 2009 ). However, our pros-RNAi data suggest a requirement of Pros in MBNB-lineage development, similar to other NB-lineages. Although nuclear Pros levels are low in postembryonic MB-GMCs, they still appear to be sufficient for the suppression of stem cell factors (e.g. Dpn) and induction of differentiation factors (e.g. Elav, Dac) (Fig. 7) . This supports that in MBNB-lineages, as reported for other NB-lineages (Bello et al. 2006; Betschinger et al. 2006; Choksi et al. 2006; Lee et al. 2006) , absence of Pros appears to transform mutant GMCs to NBs which repeatedly divide, express NB markers and fail to differentiate. Since in wild-typic MBNB-clones low levels of Pros are maintained in most, if not all KCs (see Fig. 7B ), this implies also a late function of Pros in the differentiation of KCs.
Another significant finding of this study is that Rx promotes sustained cell growth of MBNBs. Further studies have to clarify how Rx is genetically involved in growth control. Cell growth is crucial for proper proliferation of NBs. After a period of quiescence, food intake during larval stages activates the insulin and target of rapamycin pathways in dormant NBs to induce growth (Chell and Brand, 2010; Sousa-Nunes et al., 2011) . Accordingly, dormant NBs first enlarge before they re-enter the cell cycle in the larval brain and ventral nerve cord, and inhibition of cell growth prevents their reactivation (Truman and Bate, 1988; Chell and Brand, 2010; Sousa-Nunes et al., 2011; Melzer et al., 2013) . MBNBs do not undergo a period of mitotic dormancy. Despite permanent divisions, MBNBs continuously grow until the late larval stage (Melzer et al., 2013) , and decrease in size not before the late pupal stage (~72 h APF), which is accompanied by reduced proliferation (Siegrist et al., 2010) . Accordingly, growth is closely correlated with the proliferation rate of MBNBs. Therefore, we assume that the permanent growth deficit in rx-mutant MBNBs from embryonic stages onwards impairs the proliferation of these NBs. However, we cannot exclude that Rx controls the proliferation of MBNBs also more directly.
MBNBs exist much longer than other brain NBs. We show that rx expression is strongly correlated with MBNB appearance, and that rx function is essential for their survival. Nevertheless, Rx alone is not sufficient to prolong MBNB lifespan. Normally, during fasting pupal stage, changes in the nutrient status result in the nuclear localization of Foxo which inhibits growth of MBNBs through a decline in insulin and target of rapamycin pathways; activation of the cell death pathway finally eliminates the MBNBs (Siegrist et al., 2010; reviewed in Homem and Knoblich, 2012) . It still awaits further investigations to clarify how Rx is implicated in the suppression of cell death in MBNBs.
In a previous study it was shown that Rx is required for development of the ellipsoid body (Davis et al., 2003) , which is part of the central complex that forms during mid-pupal stage (Renn et al., 1999) . Using c232-Gal4 which drives expression in a subset of ellipsoid body neurons, it was shown that rx-deficient neurons disclose defects in axonal growth and/or targeting which resulted in partial loss or malformations of the ellipsoid body (Davis et al., 2003) . Since rx is expressed in many neurons of the DPM-and CM-lineages (Fig. 1F ) from which main structures of the central complex develop (Bello et al., 2008; Izergina et al., 2009; Pereanu et al., 2010; Yang et al., 2013) , it is likely that Rx is also involved in the proper development of other central complex structures. Notably, rx seems not expressed in progenitors of the DPM-lineages, which would exclude a role in proliferation control of these lineages. Accordingly, we suppose that Rx fulfils clone-specific functions in the development of the MBNB-and DPM-lineages.
Evolutionary considerations of Rx function
Previous reports showed that the early gene expression profile of the pallium (a subregion of the forebrain) in mouse reveals strong parallels with the MBs in the annelid Platynereis and Drosophila, which supports homology between these brain structures in the different taxa (Tomer et al., 2010; Kunz et al., 2012) . In vertebrates, Rx orthologs are initially expressed in progenitors of the presumptive forebrain and later also in the primordia of the eyes (Casarosa et al., 1997; Mathers et al., 1997) . Loss-of-function mutations of rx orthologs in mouse and fish resulted in developmental defects in forebrain and eye, that were lacking in severe cases (Mathers et al., 1997; Winkler et al., 2000; Zhang et al., 2000; Chuang and Raymond, 2001; Ishikawa et al., 2001; Loosli et al., 2001; Tucker et al., 2001; Bailey et al., 2004; Zilinski et al., 2004) . In Xenopus it was further shown, that overexpression of Xrx1 increased the mitotic activity specifically in the early forebrain and eye, owing to a longer persistence of dividing precursor cells during development; conversely, misexpression of a functionally inactivated, dominant-negative Xrx1 inhibited proliferation (Casarosa et al., 2003) , and increased cell death (Andreazzoli et al., 1999) . The partial rescue of the clone size of retinal progenitors after co-misexpression of the anti-apoptotic Bcl2 gene lead the suggestion that the loss of clonal cells is due to compromised proliferation and induction of apoptosis (Casarosa et al., 2003) . These observations strongly parallel our findings in the fly: rx is initially expressed in proliferative cell types of the MBs in the fly forebrain (i.e., protocerebrum; see Urbach, 2007) . Further, in the absence of rx function, MBNB clones exhibit a decrease in mitotic activity and premature cell death of MBNBs and KCs. However, even though Rx is essential for the survival of MBNBs, rx-overexpression does not expand their longevity, which may indicate a difference to the prolonged persistence of precursor cells after Xrx1-overexpression in Xenopus. Another parallel in forebrain development is that expression of Pax6/ey is activated independently of Rx in mouse (Zhang et al., 2000) and fly (this study). In eye development, however, Rx is crucial for the activation of Pax6/ey in vertebrates (Zhang et al., 2000; Zuber et al., 2003; reviewed in Muranishi et al., 2012) , albeit not in Drosophila (Eggert et al., 1998; Davis et al., 2003) . Together, these data support that Rx expression and aspects of their function are conserved in forebrain development of vertebrates and the fly. The amenable MBNBs and their lineages may therefore serve as a model system for further investigations towards a molecular understanding of Rx function in stem cells of the fly and vertebrate brain.
Luo, 1999): FRT40A, UAS-mCD8::GFP, rx 10155 flies were crossed with hsFLP; FRT40A, tubP-GAL80, ActGFP; tubP-GAL4, UAS-mCD8::GFP. To generate wild-type clones FRT40A, UAS-mCD8::GFP was used. To induce wildtype or rx-mutant MARCM clones, in all cases newly hatched larvae were heat-shocked in a 37.5°C water bath for 1 h and dissected at appropriate stages (96 h ALH, 36-48 h APF, 72 h APF, or newly hatched adults). The rx 10155 -mutant allele was identified in an EMS-mutagenesis screen for mutants of the 57B region. An EMS-induced point mutation introduced a stop codon in exon 3 resulting in a truncated Rx protein of 230 amino acids missing the homeodomain (U.W., unpublished). To generate UAS-rx transgene Drx2 cDNA (Eggert et al., 1998) was cloned into the pUAST vector and transformants established by P-element mediated germline transformation following standard methods (U.W., unpublished).
Immunohistochemistry
Embryos were dechorionated, fixed and immunostained, and flat preparations performed according to previous protocols (Patel, 1994; Jussen and Urbach, 2014) . Postembryonic brains were dissected in PBS and fixed 1 h on ice in 2% paraformaldehyde in PBL (75 mM lysineHCl in sodium phosphate buffer, pH 7.4). All washings were carried out in PBT (PBS containing 0.3% Triton X-100). After blocking in 5% normal goat serum in PBT, for antibody staining the postembryonic brains were treated in the same way as the embryos. The following primary antibodies were used: chicken anti-β-Gal (1:1000, Abcam), mouse anti-Dac (1:250, DSHB), guinea pig anti-Dpn (1:1000, Jim Skeath, St Louis, MO, USA), rabbit anti-Rx (1:1000) (Davis et al., 2003) , rat antiElav (1:400, DSHB), rabbit anti-Ey (1:1000) (Kurusu et al., 2000) , mouse anti-Nrt (1:10, DSHB), mouse anti-PH3 (1:1000, Cell Signaling), mouse anti-Pros (1:100, DSHB), rabbit anti-Tll (1:600; provided by Ralf Pflanz) (Kosman et al., 1998) . The secondary antibodies were either biotinylated, conjugated with alkaline-phosphatase, or DyLight™, Cyanine (all Jackson Immunoresearch) and Alexa (Life technologies) fluorescent dyes (all diluted 1:500). F-actin was visualized with Phalloidin-Oregon Green (1:500, Invitrogen). After embedding in Vectashield (1:1 in glycerol), the fluorescent confocal images were acquired on a Leica TCSSP5II. Non-fluorescent stainings were documented on a Zeiss-Axioplan microscope.
Image processing was carried out with the ImageJ distribution Fiji (Schindelin et al., 2012) , Leica LAS AF (2.3.5), Amira 4.0.01 (Mercury Computer Systems), Adobe Photoshop CS4 and Adobe Illustrator CS4. Measurement and counting of neurons and neuroblasts were carried out with Amira and Leica LAS AF. The diameter of Neurotactin, inscGal4 and or F-actin stained NBs and GMCs was estimated by focusing their center in z-axis and then calculating the average of the largest and smallest cell extension in x-/y-axis. A chi-square test was used for intergroup comparisons of percentages in Figs. 2J, 3F, 4I, other data were analyzed with a two-tailed unpaired Student's t-test.
EdU incorporation assay
To detect mitotic activity wandering third instar larvae (90 h ALH) were fed for 5.5 h on Drosophila instant medium (Carolina Biological Supplies) containing 2 mM EdU (Invitrogen) in PBS. The CNS of larva was dissected and fixed as described above. Alexa Fluor azide was detected according to the manufacturer's instructions (Click-iT EdU Imaging Kit, Invitrogen).
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